fda warning letters compounded semaglutide telehealth 2024 2025 September 15, 2025: company must stop implying its GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Beyond the Headlines: FDA Warning

[48]Tang M, Li R, et al

DIM, short for diindolylmethane, is a hormone balancer that can be beneficial for breast, uterine, cervical, and prostate health

Tesamorelin is a stabilized analog of growth hormonereleasing hormone (GHRH) that stimulates the pituitary to produce GH in a physiologic, pulsatile manner Ipamorelin selectively stimulates GH release via ghrelin receptors while minimizing effects on cortisol and prolactin When combined, Tesamorelin and Ipamorelin are commonly explored in integrative wellness settings for metabolic health, body composition support, recovery, sleep quality, and healthy aging

Our Comprehensive Telehealth Weight Loss Program Includes: One-on-One Virtual Consultation: Connect with expert healthcare providers who assess your health history, goals, and lifestyle to develop a personalized plan